The suppressed proliferation and premature senescence by ganciclovir in p53-mutated human non-small-lung cancer cells acquiring herpes simplex virus-thymidine kinase cDNA

Cancer Detection and Prevention

Volumn 29, Issue 3, 2005, Pages 286-293

  Chiu, C C ^a   Li, C H ^a   Fuh, T S ^a   Chen, W L ^a   Huang, C S ^a   Chen, L J ^a   Ung, W H ^a   Fang, K ^a  

^a NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

Author keywords

Herpes simplex virus thymidine kinase; Human non small cell lung cancer cells

Indexed keywords

COMPLEMENTARY DNA; GANCICLOVIR; PROTEIN P53; THYMIDINE KINASE; VIRUS DNA; VIRUS ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ARTICLE; BYSTANDER EFFECT; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CELL MUTANT; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; FEMALE; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; NUDE MOUSE; PREMATURE AGING; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; ANTIVIRAL AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GANCICLOVIR; GENES, P53; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; MUTATION; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 20344404945     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdp.2005.02.001     Document Type: Article

References (31)

1. K.M. Fong, Y. Sekido, A.F. Gazdar, and J.D. Minna Lung cancer 9: molecular biology of lung cancer: clinical implications Thorax 58 2003 892 900
2. S. Moriuchi, D.M. Krisky, and P.C. Marconi HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma Gene Ther 7 2000 1483 1490
3. C. Denning, and J.D. Pitts Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes Hum Gene Ther 8 1997 1825 1835
4. S.J. Wei, Y. Chao, and Y.M. Hung S- and G2-phase cell cycle arrests and apoptosis induced by ganciclovir in murine melanoma cells transduced with herpes simplex virus thymidine kinase Exp Cell Res 241 1998 66 75
5. H. Namba, Y. Iwadate, K. Kawamura, S. Sakiyama, and M. Tagawa Efficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin43 in the target cells Cancer Gene Ther 8 2001 414 420
6. K.J. Pulkkanen, J.J. Parkkinen, and J.M. Laukkanen HSV-tk gene therapy for human renal cell carcinoma in nude mice Cancer Gene Ther 8 2001 529 536
7. M.A. Shibata, J. Morimoto, and Y. Otsuki Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation Cancer Gene Ther 9 2002 16 27
8. A.J. Pantuck, J. Matherly, and A. Zisman Optimizing prostate cancer suicide gene therapy using herpes simplex virus thymidine kinase active site variants Hum Gene Ther 13 2002 777 789
9. Y. Sakai, S. Kaneko, Y. Nakamoto, T. Kagaya, N. Mukaida, and K. Kobayashi Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma Cancer Gene Ther 8 2001 695 704
10. T. Okino, M. Onda, and N. Matsukura Sequential histopathological changes in vivo after suicide gene therapy of gastric cancer induced by N-methyl-N′-nitro-N-nitrosoguanidine in rats Jpn J Cancer Res 92 2001 673 679
11. C.C. Chiu, Y.L. Kang, T.H. Yang, C.H. Huang, and K. Fang Ectopic expression of herpes simplex virus-thymidine kinase gene in human non-small cell lung cancer cells conferred caspase-activated apoptosis sensitized by ganciclovir Int J Cancer 102 2002 328 333
12. B.G. Campling, and W.S. El-Deiry Clinical implication of p53 mutation in lung cancer Mol Biotechnol 24 2003 141 156
13. T. Mitsudomi, S.M. Steinberg, and M.M. Nau p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features Oncogene 7 1992 171 180
14. N.W. Kim, M.A. Piatyszek, and K.R. Prowse Specific association of human telomerase activity with immortal cells and cancer Science 266 1994 2011 2015
15. G.P. Dimri, X. Lee, and G. Basile A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92 1995 9363 9367
16. A. Noda, Y. Ning, S.F. Venable, O.M. Pereira-Smith, and J.R. Smith Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen Exp Cell Res 211 1994 90 98
17. Y. Hirose, M.S. Berger, and R.O. Pieper Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells Cancer Res 61 2001 5843 5849
18. G. Saretzki Telomerase inhibition as cancer therapy Cancer Lett 194 2003 209 219
19. J.W. Shay, and I.B. Roninson Hallmarks of senescence in carcinogenesis and cancer therapy Oncogene 23 2004 2919 2933
20. J.W. Shay, H. Werbin, W.D. Funk, and W.E. Wright Cellular and molecular advances in elucidating p53 function Mutat Res 277 1992 163 171
21. Z. Han, W. Wei, and S. Dunaway Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin J Biol Chem 277 2002 17154 17160
22. L. Fang, M. Igarashi, J. Leung, M.M. Sugrue, S.W. Lee, and S.A. Aaronson p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53 Oncogene 18 1999 2789 2797
23. M. Olivier, S.P. Hussain, C. Caron de Fromentel, P. Hainaut, and C.C. Harris TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer IARC Sci Publ 2004 247 270
24. F.L. Chang, and M.D. Lai Various forms of mutant p53 confer sensitivity to cisplatin and doxorubicin in bladder cancer cells J Urol 166 2001 304 310
25. R. Kurdow, A.S. Boehle, and S. Haye Ganciclovir prodrug therapy is effective in a murine xenotransplant model of human lung cancer Ann Thorac Surg 73 2002 905 910
26. M.T. Tomicic, R. Thust, R.W. Sobol, and B. Kaina DNA polymerase beta mediates protection of mammalian cells against ganciclovir-induced cytotoxicity and DNA breakage Cancer Res 61 2001 7399 7403
27. A.M. Maatta, A. Tenhunen, and T. Pasanen Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy Int J Oncol 24 2004 943 949
28. I.J. van Dillen, N.H. Mulder, W. Vaalburg, E.F. de Vries, and G.A. Hospers Influence of the bystander effect on HSV-tk/GCV gene therapy A review. Curr Gene Ther 2 2002 307 322
29. J.H. Kim, G.E. Lee, S.W. Kim, and I.K. Chung Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells Biochem J 373 2003 523 529
30. M.T. Tomicic, E. Bey, P. Wutzler, R. Thust, and B. Kaina Comparative analysis of DNA breakage, chromosomal aberrations and apoptosis induced by the anti-herpes purine nucleoside analogues aciclovir, ganciclovir and penciclovir Mutat Res 505 2002 1 11
31. Y. Wang, S. Zhu, T.F. Cloughesy, L.M. Liau, and P.S. Mischel p53 disruption profoundly alters the response of human glioblastoma cells to DNA topoisomerase I inhibition Oncogene 23 2004 1283 1290